May 12, 2015
Moderna Launches Third Venture Company Elpidera for Rare Diseases
March 16, 2015
Moderna Appoints Tal Zaks, Former Head of Sanofi Global Oncology, as Chief Medical Officer
February 03, 2015
Moderna and Institut Pasteur Sign Strategic Research Collaboration
January 13, 2015
Moderna Announces License and Collaboration Agreement with Merck to Develop Messenger RNA-based Antiviral Vaccines and Passive Immunity Therapies
January 08, 2015
Moderna Launches New Venture Valera LLC for Infectious Diseases
January 07, 2015
Onkaido Announces Appointment of Michael J. Morin, Ph.D., as Chief Scientific Officer
January 06, 2015
Moderna to Present at 33rd Annual J.P. Morgan Healthcare Conference
January 05, 2015
Moderna Closes $450 Million Financing to Support Growth of Messenger RNA Therapeutics™ Platform across Diverse Therapeutic Areas
October 16, 2014
Moderna to Collaborate with Karolinska Institutet and Karolinska University Hospital on Discovery of New Messenger RNA Therapeutics™
July 01, 2014
Moderna Appoints Oncology Leader Dr. Stephen Kelsey as President of Onkaido

Pages